Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ UBE2L6 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA589352
Description
Positive Samples: U-87MG, Jurkat, Mouse kidney, Mouse liver, Mouse lung, Mouse spleen, Rat kidney, Rat liver Immunogen sequence: KTCQVLEALN VLVNRPNIRE PLRMDLADLL TQNPELFRKN AEEFTLRFGV DRPS.
The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes (E1s), ubiquitin-conjugating enzymes (E2s) and ubiquitin-protein ligases (E3s). UBE2L6 is a member of the E2 ubiquitin-conjugating enzyme family. This enzyme is demonstrated to function in the E6/E6-ap-induced ubiquitination of p53.
Specifications
UBE2L6 | |
Polyclonal | |
Unconjugated | |
UBE2L6 | |
2810489I21Rik; E2 ubiquitin conjugating enzyme; E2 ubiquitin-conjugating enzyme L6; MGC40331; retinoic acid induced gene B protein; retinoic acid-induced gene B protein; RIG-B; Ubce8; UBCH8; Ubcm8; UBE2L6; Ubiquitin carrier protein L6; ubiquitin conjugating enzyme E2 L6; ubiquitin conjugating enzyme E2L 6; Ubiquitin/ISG15-conjugating enzyme E2 L6; ubiquitin-conjugating enzyme 8; ubiquitin-conjugating enzyme E2L 6; Ubiquitin-protein ligase L6 | |
Rabbit | |
Affinity chromatography | |
RUO | |
295704, 56791, 9246 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Liquid |
ELISA, Western Blot, Immunocytochemistry | |
0.53 mg/mL | |
PBS with 50% glycerol and 0.05% ProClin 300; pH 7.3 | |
O14933, Q4V8J2, Q9QZU9 | |
UBE2L6 | |
A synthetic peptide corresponding to a sequence within amino acids 100-153 of human UBE2L6 (NP_0042141). | |
100 μL | |
Primary | |
Human, Mouse, Rat | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction